(Q45375405)

13 December 2017

title

Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma (English)

1 reference

13 December 2017

8

1 reference

13 December 2017

C G Stoehr

1

1 reference

13 December 2017

R Stoehr

2

1 reference

13 December 2017

A Hartmann

3

1 reference

13 December 2017

F Hofstaedter

4

1 reference

13 December 2017

K Junker

5

1 reference

13 December 2017

H Blaszyk

6

1 reference

13 December 2017

W F Wieland

7

1 reference

13 December 2017

S Denzinger

9

1 reference

13 December 2017

B Walter

10

1 reference

13 December 2017

publication date

28 December 2011

1 reference

Journal of Cancer Research and Clinical Oncology

13 December 2017

published in

1 reference

13 December 2017

volume

138

1 reference

13 December 2017

issue

2

1 reference

13 December 2017

page(s)

359-361

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-011-1130-x

13 December 2017

exact match

0 references

cites work

Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1130-X

Role of fibroblast growth factor receptor signaling in kidney development

21 January 2018

1 reference

12 December 2020

Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma.

1 reference

12 December 2020

A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine

1 reference

12 December 2020

FGFR3 mutation in thanatophoric dysplasia type 1 with bilateral cystic renal dysplasia: coincidence or a new association?

1 reference

12 December 2020

Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease

1 reference

12 December 2020

10.1007/S00432-011-1130-X

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1035531707

0 references

1 reference